Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

Journal of Medicinal Chemistry
2004.0

Abstract

The discovery and synthesis of dihydrobenzoxathiins as potent, ERalpha subtype selective ligands are described. The most active analogue, 4-D, was found to be 50-fold selective in a competitive binding assay and 100-fold selective in a transactivation assay in HEK-293 cells. The alpha selectivity was postulated to lie in the interaction of the sulfur atom of the benzoxathiin ring with the two discriminating residues in the binding pocket of the receptor isoforms.

Knowledge Graph

Similar Paper

Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators
Journal of Medicinal Chemistry 2004.0
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor α and their bioactivities in vivo
Bioorganic & Medicinal Chemistry Letters 2005.0
Hydrophobic Interactions Improve Selectivity to ERα for Benzothiophene SERMs
ACS Medicinal Chemistry Letters 2012.0
Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators
Bioorganic & Medicinal Chemistry Letters 2005.0
Selective Estrogen Receptor Modulators with Conformationally Restricted Side Chains. Synthesis and Structure−Activity Relationship of ERα-Selective Tetrahydroisoquinoline Ligands
Journal of Medicinal Chemistry 2005.0
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity
Journal of Medicinal Chemistry 2018.0
Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity
Bioorganic & Medicinal Chemistry Letters 2004.0
2-Amino-4,6-diarylpyridines as novel ligands for the estrogen receptor
Bioorganic & Medicinal Chemistry Letters 2001.0